Rankings
▼
Calendar
EKSO FY 2022 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena
EKSO
Ekso Bionics Holdings, Inc.
$29M
FY 2022 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$13M
+14.8% YoY
Gross Profit
$6M
48.1% margin
Operating Income
-$16M
-120.5% margin
Net Income
-$15M
-116.8% margin
EPS (Diluted)
$-1.16
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$15M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$41M
Total Liabilities
$15M
Stockholders' Equity
$25M
Cash & Equivalents
$21M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$13M
$11M
+14.8%
Gross Profit
$6M
$7M
-7.9%
Operating Income
-$16M
-$14M
-12.5%
Net Income
-$15M
-$10M
-54.4%
← Q4 2021
All Quarters
Q1 2022 →